The Chief Medical Officer (CMO) and Chief Pharmaceutical Officer (CPO) have met with the clinical leadership team from NHS Greater Glasgow and Clyde (NHSGGC), and are currently considering what, if any, actions may be required to provide assurance of the medicine governance arrangements and the prescribing practices for immunosuppressed patients in paediatric services at the Queen Elizabeth University Hospital (QEUH). S6W...